Back to VRDN
MARSHALL WACE, LLP VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$41M
Q4 2025
Peak value
$41M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $120K |
| Q1 2023 | $15.9M |
| Q2 2023 | $15.5M |
| Q3 2023 | $14.8M |
| Q4 2023 | $6.6M |
| Q1 2024 | $1.4M |
| Q2 2024 | $949K |
| Q3 2024 | $592K |
| Q3 2024 | $15M |
| Q1 2025 | $14.6M |
| Q2 2025 | $16.9M |
| Q3 2025 | $18.8M |
| Q4 2025 | $1.8M |
| Q4 2025 | $41M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $41M | 1.32M | — | — |
| Q4 2025 | $1.8M | 57.3K | — | — |
| Q3 2025 | $18.8M | 869.2K | — | — |
| Q2 2025 | $16.9M | 1.21M | — | — |
| Q1 2025 | $14.6M | 1.08M | — | — |
| Q3 2024 | $15M | 658.8K | — | — |
| Q3 2024 | $592K | 26.0K | — | — |
| Q2 2024 | $949K | 73.0K | — | — |
| Q1 2024 | $1.4M | 78.7K | — | — |
| Q4 2023 | $6.6M | 301.3K | — | — |
| Q3 2023 | $14.8M | 962.5K | — | — |
| Q2 2023 | $15.5M | 651.2K | — | — |
| Q1 2023 | $15.9M | 624.6K | — | — |
| Q1 2023 | $120K | 4.7K | — | — |
Other funds holding VRDN
$112.5M
$112.5M
$91.4M
$46.7M
$42.8M